GL1X · GenesisL1 explorer

Research workbench

Structure of murine inos oxygenase domain with inhibitor ar-C118901

Analyse Structure of murine inos oxygenase domain with inhibitor ar-C118901 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3E6T
Type
protein
Length
825 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Nitric oxide synthase, inducible
EC
1.14.13.39
UniProt
P29477
Ligands
HEM, H4B, 1A2
Pockets
8 · best druggability 0.81

Structure

x-ray diffraction · 2 distinct chains · 41% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANitric oxide synthase, inducible (EC 1.14.13.39)protein41540% helix, 14% strandP29477
BNitric oxide synthase, inducible (EC 1.14.13.39)protein41042% helix, 15% strandP29477

Ligands and binding sites

  • HEM · Protoporphyrin IX containing Fe · ligand · 2 copies · chains A, B
  • H4B · 5,6,7,8-tetrahydrobiopterin · ligand · 2 copies · chains A, B
  • 1A2 · 5-(4'-amino-1'-ethyl-5',8'-difluoro-1'H-spiro[piperidine-4,2'-quinazoline]-1-ylcarbonyl)picolinonitrile · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

8 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111930.810.8279HEM, H4B, 1A2
211920.800.8180HEM, H4B, 1A2
32510.570.7829empty
4990.490.8220empty
5840.450.8118empty

Interfaces

1 interface between chains.

  • A–B · 152 Ų buried · 0 hydrogen bonds · protein-protein

Compared structures

  • 3E6T · Structure of murine INOS oxygenase domain with inhibitor AR-C118901 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.